Long-term welfare consequences of sleep apnea in 20-64-year-olds - influence of gender: A nationwide cohort study
Abstract
STUDY OBJECTIVES
Obstructive sleep apnea (OSA) is associated with a significant welfare burden. Little information is available about long-term welfare consequences for women and men. Here we evaluated the long-term gender-associated welfare of patients with OSA.
METHODS
Using data from the Danish National Patient Registry and other public databases, all patients aged 20-64 years with a diagnosis of OSA were included. They were compared with citizens matched by age, sex, marital status, and community location, in a ratio of 1:4. All health and social costs were included from public registries.
RESULTS
A total of 55,783 men and 19,241 women with OSA were compared with 223,783 and 76,961 controls, respectively. As a group, people with OSA had significantly higher morbidity, mortality, health costs, transfer incomes, sickness benefits, whereas their educational level, and professional affiliation were lower, and patients retired earlier than their corresponding controls. These patterns could be identified as much as 15 years before diagnosis, with changes becoming more pronounced after diagnosis and management. There was a significant gender difference, whereby women had higher morbidity and mortality rates and social welfare social costs than men in all domains, before and after diagnosis. The total case patient net costs for men/women were 4217/8259 €/year before diagnosis and 8749/13730 €/year after diagnosis.
CONCLUSIONS
OSA is associated with a significant welfare burden…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 55,783 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.